Table 1

Expression levels of TAp63 and ΔNp63 mRNA in human bladder tissues and cell linesa

CLbTissuesStageGrade
NCaTa-T1T2-T4IIIIII
Specimen no.412472522181613
Expression (/GAPDH)c
TAp63
4–5 (>0.99)07 (58.3)11 (23.4)8 (36.0)3 (13.6)6 (33.3)4 (25.0)1 (7.9)
3 (0.49–0.98)15 (41.7)11 (23.4)10 (40.0)1 (4.5)5 (27.8)5 (31.3)1 (7.9)
2 (0.26–0.48)30 (0.0)17 (36.2)6 (24.0)11 (50.0)6 (33.3)5 (31.3)6 (46.2)
0–1 (<0.25)00 (0.0)8 (17.0)1 (4.0)7 (31.8)1 (5.6)2 (12.5)5 (38.5)
ΔNp63
4–5 (>0.79)20 (0.0)14 (29.8)7 (28.0)7 (31.8)5 (27.8)5 (31.3)4 (30.8)
3 (0.39–0.78)00 (0.0)16 (34.0)9 (36.0)7 (31.8)6 (33.3)6 (37.5)4 (30.8)
2 (0.19–0.38)07 (58.3)8 (17.0)4 (16.0)4 (18.2)3 (16.7)3 (18.8)2 (15.4)
0–1 (<0.19)25 (41.7)9 (19.1)5 (20.0)4 (18.2)4 (22.2)2 (12.5)3 (23.1)
  • a Numbers in parentheses are percentage.

  • b CL, cell lines; N, normal; Ca, carcinoma.

  • c Expression levels (0–5) were classified based on the ratio of p63/GAPDH.